GLP-1 NAION Lawsuit MDL 3163: Case Management Orders (CMOs)
Track the latest legal updates, scheduling protocols, and Case Management Orders (CMOs) in MDL 3163: In Re: GLP-1 Receptor Agonists NAION Products Liability Litigation. Bookmark this page for a chronological log of court filings regarding Ozempic and Wegovy vision loss claims.
GLP-1 NAION Lawsuit: Vision Loss & Blindness Claims
If you or a loved one experienced sudden vision loss or were diagnosed with NAION (eye stroke) after taking GLP-1 medications like Ozempic or Wegovy, you may be entitled to significant compensation. Learn about the latest legal updates in MDL 3163 and see if you qualify for a free case evaluation today.
